Home › Interstitial Lung Diseases › North Carolina › Durham
Interstitial Lung Diseases clinical trials in Durham, NC
13 studies for Interstitial Lung Diseases are looking for participants at sites in and around Durham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
RecruitingPhase 2
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi away
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
RecruitingObservational study
- Duke University, Durham
- UNC Chapel Hill, Chapel Hill · 10 mi away
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RecruitingPhase 3
- USA011, Durham
- USA022, Chapel Hill · 10 mi away
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
RecruitingPhase 2/3
- Duke University, Durham
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
RecruitingPhase 3
- GSK Investigational Site, Durham
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RecruitingObservational study
- Duke University School of Medicine, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi away
Platform Clinical Study for Conquering Scleroderma
RecruitingPhase 2
- Duke University Medical Center, Durham
H01 in Adults With Interstitial Lung Disease (The SOLIS Study)
RecruitingPhase 2
- NIEHS Clinical Research Unit (CRU), Research Triangle Park · 7 mi away
Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
RecruitingPhase 2
- Duke University Health System, Durham
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
RecruitingPhase 3
- Duke University Medical Center, Durham
Pulmonary Hypertension SOLAR
RecruitingPhase 2
- Duke University Medical Center, Durham
129Xe MRI Cardiopulmonary
RecruitingPhase 2Healthy volunteers welcome
- Duke University Medical Center, Durham
Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
RecruitingPhase 2Healthy volunteers welcome
- Duke University Medical Center, Durham
About Interstitial Lung Diseases
Interstitial lung diseases are a group of diseases that inflame or scar the lungs. Breathing in particles (asbestosis, silicosis) causes some types.
More about Interstitial Lung Diseases on MedlinePlus
Interstitial Lung Diseases trials in other cities
- New York City, NY17 studies
- Philadelphia, PA16 studies
- Los Angeles, CA14 studies
- Kansas City, KS13 studies
- Houston, TX12 studies
- Chicago, IL12 studies
- Charleston, SC11 studies
- Ann Arbor, MI11 studies
- Aurora, CO10 studies
- Boston, MA9 studies
- Rochester, MN9 studies
- Salt Lake City, UT9 studies
Other studies in Durham
- Breast Cancer63 studies
- Cancer (all types)61 studies
- Non-Small Cell Lung Cancer42 studies
- Multiple Myeloma36 studies
- Acute Myeloid Leukemia34 studies
- Lung Cancer33 studies
- Metastatic Cancer33 studies
- Prostate Cancer32 studies
- Colorectal Cancer30 studies
- Ovarian Cancer28 studies
- Chronic Lymphocytic Leukemia28 studies
- Heart Failure25 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.